课题基金 / 基金详情

Mechanism of Regulation of Tyrosine Kinase Signaling

Mechanism of Regulation of Tyrosine Kinase Signaling
酪氨酸激酶信号传导的调节机制
批准号:
12219216
负责人:
YOSHIMURA Akihiko
金额:
$109.76万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2004

项目摘要

项目成果

YOSHIMURA Akihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most of growth factor receptors transmit signals through tyrosine kinases which is encoded in the intracellular domain, or non-covalently associated JAK kinases like cytokine receptors. Constitutive activation of tyrosine kinase is frequently associated with neoplasm and leukemic development ; for example Bcr-Abl for chronicmyelogenous leukemia. Furthermore, downstream moleculessuchas Ras and STATs play important roles in intracellular signal transduction as well as cancer development.On the other hand, signal of cytokine plays important role on development of carcinogenesis and cancer through control of immune system as well as cell growth. About 20% of carcinoma has been thought to be derived from inflammation, however, there are many questions remained to be solved about inflammatory cytokines and their signals and carcinogenesis. Recently the TNF/NF-kB pathway has been implicated in inflammation-derived cancer, while we have investigated the STAT pathway, another important signal o … More f inflammatory cytokines. We have also investigated Ras/MAP kinase regulator Sprouty/Spred family proteins. Anti-tumor activity of SOCS1, a negative regulator of cytokine signaling, has been reported by many groups. SOCS1 may inhibit the development and/or progression of hepatocellular carcinoma, since SOCS1 expression is significantly reduced in HCC cells due to hyper-methylation of SOCS1 gene. In support of this, We have shown that SOCS1 heterozygous mice are hypersensitive to dimethylnitrosamine-induced hepatocarcinogenesis. In addition we have shown that reduction of SOCS1 expression is strongly associated with hepatitis and fibrosis. Thus, SOCS1 is a unique anti-oncogene that prevents inflammation-induced cancer. We also found that SOCS1 bound to oncogene product E7 of HPV, and induces degradation of E7, which results in the suppression of proliferation of cervical tumor cells, In addition, we found that Spred-1 interacts with not only Ras but also Rho and inhibits cell motility and metastasis of cancer cell. Less
期刊论文(80)
专著(0)
科研奖励(0)
会议论文
Ohtsuka S, Takaki S, Yoshimura A, et al.: "SH2-B is Required for both Male and Female Reproduction Mol."Cell. Biol. 22. 3066-3077 (2002)
Ohtsuka S、Takaki S、Yoshimura A 等人:“男性和女性生殖分子都需要 SH2-B”细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SOCS1 inhibits HPV-E7 mediated transformation by inducing degradation of E7 protein.
SOCS1 通过诱导 E7 蛋白降解来抑制 HPV-E7 介导的转化。
DOI: --
发表时间: 2004
期刊: Oncogene 23
影响因子: --
作者: [Kamio M, et al.]
通讯作者: et al.
Saeki K, Miura Y, Aki D, Yoshimura A, et al.: "The B cell-specific major raft protein, Raftlin is necessary for the integrity of lipid raft and BCR signal transduction."EMBO J. 22. 3015-3026 (2003)
Saeki K、Miura Y、Aki D、Yoshimura A 等人:“B 细胞特异性主要筏蛋白 Raftlin 对于脂筏和 BCR 信号转导的完整性是必需的。”EMBO J. 22. 3015-3026 (
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasaki A, Taketomi T, Wakioka T, et al.: "Identification of a dominant negative from of Sproutys that potentiates FGF-induced ERK activation"J. Biol. Chem.. 276. 35185-35193 (2001)
Sasaki A、Taketomi T、Wakioka T 等人:“从 Sproutys 中鉴定出增强 FGF 诱导的 ERK 激活的显性失活”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
32
    Immune systems involved in the resolution of inflammation and tissue repair
    • 批准号:
      17H06175
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $131.71万
    • 财政年份:
      2017
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    Identification of Cellular Signaling Mechanism that regulates inflammation and tissue repairing
    • 批准号:
      25221305
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $122.8万
    • 财政年份:
      2013
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    Systemic Biology of T cell differentiation
    • 批准号:
      25670234
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    Systembiology of T-cell differentiation
    • 批准号:
      23659242
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    国内基金
    海外基金
    乌司他丁靶向抑制HDAC1通过SOCS1/JAK2/STAT3 轴调控小胶质细胞极化来减轻局灶性脑缺血再灌注损伤的机制研究
    • 批准号:
      2026JJ81821
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈晓曦
    • 依托单位:
    IFN- α 通过SOCS3/JAK2/STAT5通路调控 H3N2流感病毒引起的鼻黏膜嗜酸性粒细 胞浸润性炎症的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      洪海裕
    • 依托单位:
    参附方靶向SOCS3/JAK2相互作用调控JAK2/STAT3通路改善肝缺血再灌注损伤的物质基础与作用机理研究
    • 批准号:
      JCZRLH202500794
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    温针灸通过SOCS3负反馈调节JAK1/STAT3信号通路影响CAG小鼠胃黏膜炎症微环境的机制研究
    • 批准号:
      2025JJ70548
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      冯芳
    • 依托单位: